Matches in Wikidata for { <http://www.wikidata.org/entity/Q65471552> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q65471552 description "clinical trial" @default.
- Q65471552 description "ensayu clínicu" @default.
- Q65471552 description "klinisch onderzoek" @default.
- Q65471552 description "клінічне випробування" @default.
- Q65471552 name "Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer" @default.
- Q65471552 name "Cetuximab" @default.
- Q65471552 type Item @default.
- Q65471552 label "Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer" @default.
- Q65471552 label "Cetuximab" @default.
- Q65471552 prefLabel "Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer" @default.
- Q65471552 prefLabel "Cetuximab" @default.
- Q65471552 P1132 Q65471552-009AAFBB-5BE0-4601-95A9-6D2DED084EA6 @default.
- Q65471552 P1476 Q65471552-FC7DA5DD-8282-4588-8730-1AD95668BFE4 @default.
- Q65471552 P17 Q65471552-01E06C38-9E01-4FE8-8E7B-A59006D45AAC @default.
- Q65471552 P1813 Q65471552-1767BFD9-6969-4510-9FE2-5470AFD434CC @default.
- Q65471552 P2899 Q65471552-DA85E49C-42F0-40CC-88AD-C9D5643F0C9D @default.
- Q65471552 P3098 Q65471552-2AF9E13C-2DFE-40FD-B862-D9196BDB5ED0 @default.
- Q65471552 P31 Q65471552-6A4E6B6D-C91D-4318-A4C9-07A821A2171C @default.
- Q65471552 P580 Q65471552-F0FFE022-7C2A-4A16-82A3-B14944633718 @default.
- Q65471552 P582 Q65471552-FD8C3D1A-A203-437C-A7E7-FB171AA810E4 @default.
- Q65471552 P6099 Q65471552-A788E813-4E0F-4FC7-92FC-CA1CF0F766B7 @default.
- Q65471552 P6153 Q65471552-2AF766DB-7C1F-4E7A-9066-A167AEC6545C @default.
- Q65471552 P767 Q65471552-239E4A09-9D66-4035-912B-0FC5F7E2B37B @default.
- Q65471552 P8363 Q65471552-186803CE-1B70-4070-85DE-567CB8F3FA29 @default.
- Q65471552 P1132 "+110" @default.
- Q65471552 P1476 "A Randomized Phase II Trial of Concurrent Chemoradiation With Cetuximab (ERBITUX®), 5 Fluorouracil, Hydroxyurea, and Twice-daily Radiation (CetuxFHX) Versus Cetuximab (ERBITUX®), Cisplatin, and Accelerated Radiation With Concomitant Boost (CetuxPX) After Induction Chemotherapy in Patients With Locally Advanced Head and Neck Cancer" @default.
- Q65471552 P17 Q30 @default.
- Q65471552 P1813 "EPIC" @default.
- Q65471552 P2899 "+18" @default.
- Q65471552 P3098 "NCT00468169" @default.
- Q65471552 P31 Q30612 @default.
- Q65471552 P580 "2006-07-01T00:00:00Z" @default.
- Q65471552 P582 "2012-08-01T00:00:00Z" @default.
- Q65471552 P6099 Q42824440 @default.
- Q65471552 P6153 Q131252 @default.
- Q65471552 P767 Q266423 @default.
- Q65471552 P8363 Q78089383 @default.